MS4A1 and hepatocellular carcinoma: In support of this observation, a study on hepatocellular carcinoma (HCC) indicated that CD20+ TIBs were positively correlated with small tumor size and the increase of CD20+ TIBs was significantly correlated with the overall and recurrence-free survival rate of HCC patients 48.